Stay updated on Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial

Sign up to get notified when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T06:08:02.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.8%
    Check dated 2025-04-30T14:13:53.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed information about a clinical trial for non-favorable risk AML patients and the addition of a new version revision and collaborators.
    Difference
    14%
    Check dated 2025-04-23T11:11:53.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.4%
    Check dated 2025-04-09T05:13:22.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-03-25T13:26:38.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-03-11T03:57:22.000Z thumbnail image

Stay in the know with updates to Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lymphodepletion & Anti-PD-1 to Reduce AML Relapse Clinical Trial page.